Artia Global Partners LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Artia Global Partners LP disclosed 44 US equity positions worth $353.6m in its Q3 2024 13F filing. The largest position was NVO at 25.0% of the reported book, followed by LLY and VKTX.
What did Artia Global Partners LP own in Q3 2024? Top 44 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | NVO NOVO-NORDISK A S | Healthcare | 25.0% | $88.3m | 741,743 | – | |
| 2 | LLY ELI LILLY & CO | Healthcare | 23.2% | $82.0m | 92,593 | – | |
| 3 | VKTX VIKING THERAPEUTICS INC | Healthcare | 9.5% | $33.7m | 532,879 | – | |
| 4 | ITCIEUR INTRA-CELLULAR THERAPIES INC | 4.5% | $15.8m | 216,519 | – | ||
| 5 | AZN ASTRAZENECA PLC | Healthcare | 4.2% | $14.9m | 190,752 | – | |
| 6 | SLNOEUR SOLENO THERAPEUTICS INC | 3.9% | $13.9m | 274,424 | – | ||
| 7 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 2.7% | $9.6m | 35,000 | – | |
| 8 | VRTX VERTEX PHARMACEUTICALS INC | Healthcare | 2.5% | $8.8m | 18,900 | – | |
| 9 | PCVX VAXCYTE INC | Healthcare | 2.5% | $8.7m | 76,255 | – | |
| 10 | ARGX ARGENX SE | Healthcare | 2.3% | $8.2m | 15,138 | – | |
| 11 | AXSM AXSOME THERAPEUTICS INC | Healthcare | 2.2% | $7.9m | 87,848 | – | |
| 12 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 1.6% | $5.6m | 124,440 | – | |
| 13 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 1.5% | $5.2m | 45,000 | – | |
| 14 | RVMD REVOLUTION MEDICINES INC | Healthcare | 1.2% | $4.3m | 95,885 | – | |
| 15 | DYN DYNE THERAPEUTICS INC | Healthcare | 1.2% | $4.3m | 119,488 | – | |
| 16 | VRNA VERONA PHARMA PLC | 1.2% | $4.3m | 148,590 | – | ||
| 17 | MERUS N V | 1.1% | $4.0m | 80,171 | – | ||
| 18 | INSM INSMED INC | Healthcare | 1.1% | $3.9m | 52,939 | – | |
| 19 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 0.7% | $2.6m | 75,300 | – | |
| 20 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 0.7% | $2.3m | 45,765 | – | ||
| 21 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 0.6% | $2.0m | 62,992 | – | |
| 22 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 0.5% | $1.7m | 421,359 | – | |
| 23 | SWTXUSD SPRINGWORKS THERAPEUTICS INC | 0.5% | $1.7m | 53,930 | – | ||
| 24 | NUVALENT INC | 0.4% | $1.6m | 15,437 | – | ||
| 25 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.4% | $1.6m | 40,000 | – | |
| 26 | CNTA CENTESSA PHARMACEUTICALS PLC | 0.4% | $1.3m | 80,380 | – | ||
| 27 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 0.4% | $1.2m | 156,300 | – | |
| 28 | CRL CHARLES RIV LABS INTL INC | Healthcare | 0.4% | $1.2m | 6,305 | – | |
| 29 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 0.3% | $1.2m | 30,479 | – | |
| 30 | KROS KEROS THERAPEUTICS INC | Healthcare | 0.3% | $1.2m | 20,000 | – | |
| 31 | KURA KURA ONCOLOGY INC | Healthcare | 0.3% | $1.1m | 57,178 | – | |
| 32 | ASND ASCENDIS PHARMA A/S | Healthcare | 0.3% | $1.1m | 7,440 | – | |
| 33 | ANNX ANNEXON INC | Healthcare | 0.3% | $1.0m | 172,226 | – | |
| 34 | CRBP CORBUS PHARMACEUTICALS HLDGS | Healthcare | 0.3% | $977.9k | 47,400 | – | |
| 35 | SLN SILENCE THERAPEUTICS PLC | 0.3% | $954.0k | 52,476 | – | ||
| 36 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 0.3% | $929.1k | 48,263 | – | |
| 37 | NEWAMSTERDAM PHARMA COMPANY | 0.3% | $901.1k | 54,285 | – | ||
| 38 | ALEC ALECTOR INC | Healthcare | 0.3% | $900.9k | 193,317 | – | |
| 39 | IRON DISC MEDICINE INC | Healthcare | 0.2% | $660.4k | 13,440 | – | |
| 40 | LRMR LARIMAR THERAPEUTICS INC | Healthcare | 0.2% | $592.7k | 90,490 | – | |
| 41 | ACELYRIN INC | 0.1% | $459.1k | 93,114 | – | ||
| 42 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 0.1% | $330.4k | 1,557 | – | |
| 43 | SMMT SUMMIT THERAPEUTICS INC | Healthcare | 0.1% | $317.8k | 14,512 | – | |
| 44 | QTTB Q32 BIO INC | 0.1% | $209.9k | 4,705 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.